ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
Diana Carvalho(Institute of Cancer Research), Chris Jones(Institute of Cancer Research)
Cited by 120
Related Papers
MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase–Mediated <i>HOX</i>/Stem Cell Gene Signature
|Cancer Research|2010|158
c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumours
|Journal of Clinical Pathology|2007|29
Distinct Phenotypic Differences Associated with Differential Amplification of Receptor Tyrosine Kinase Genes at 4q12 in Glioblastoma
|PLoS ONE|2013|26
Loss of the H4 lysine methyltransferase KMT5B drives tumorigenic phenotypes by depleting H3K27me3 at loci otherwise retained in H3K27M mutant DIPG cells
|bioRxiv (Cold Spring Harbor Laboratory)|2021|0